What is NDC 73352-830?

73352-830 is the product NDC for Tridacaine II (lidocaine), Lidocaine 50 mg/g patch, listed with the FDA by Trifluent Pharma LLC.

Trifluent Pharma LLC, NDC labeler code 73352. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Tridacaine II?

None: this is the only finished product listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Tridacaine II NDC 73352-830 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)73352-830Labeler and product segments. Claims need a package NDC.

Product NDC at billing width73352-0830Add the package segment from the table below.

Product information

Brand name (proprietary): Tridacaine II
Generic name (nonproprietary): lidocaine
Active ingredients: Lidocaine — 50 mg/g
Dosage form: Patch
Route: Topical
Labeler: Trifluent Pharma LLCNDC labeler code 73352
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 200675
Marketing start: May 20, 2024
Marketing end: Aug 31, 2027
Other FDA classes: Amides (Chemical structure)Local Anesthesia (Physiologic effect)
Identifiers: Product ID 73352-830_1377358e-4ddd-4d03-96ab-c6906f49c172SPL ID 1377358e-4ddd-4d03-96ab-c6906f49c172SPL set ID 1e940ba6-3916-4fc4-8886-481fc9685fc1RxCUI 1745091, 2678310UNII 98PI200987UPC 0373352830152
Pharmacologic class: Amide Local Anesthetic; Antiarrhythmic

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match: No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.

Product label

Current FDA label (SPL), effective Jun 12, 2026.

Indications (excerpt from the label)

INDICATION AND USAGE Lidocaine patch 5% is indicated for relief of pain associated with post-herpetic neuralgia. It should be applied only to intact skin.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 73352-830

What is NDC 73352-830?: 73352-830 is the product NDC for Tridacaine II (lidocaine), Lidocaine 50 mg/g patch, listed with the FDA by Trifluent Pharma LLC.
What drug is associated with this NDC?: Tridacaine II (Lidocaine).
What is the active ingredient?: Lidocaine.
Who is the labeler?: Trifluent Pharma LLC, NDC labeler code 73352. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Tridacaine II?: None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other NDCs under ANDA 200675

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 200675
Product	Strength	Form · route	Labeler	Product NDC
Lidocaine	Lidocaine 50 mg/g	PatchTopical	Bryant Ranch Prepack	63629-5094
Lidocaine	Lidocaine 50 mg/g	PatchTopical	AVKARE	42291-495
Lidocaine	Lidocaine 50 mg/g	PatchCutaneous	Bryant Ranch Prepack	63629-7059
Lidocaine	Lidocaine 50 mg/g	PatchTopical	Actavis Pharma, Inc.	0591-3525
Lidocaine	Lidocaine 50 mg/g	PatchTopical	Bryant Ranch Prepack	63629-8755
Lidocaine	Lidocaine 50 mg/g	PatchCutaneous	Cardinal Health 107, LLC	55154-2665
Lidocaine	Lidocaine 50 mg/g	PatchTopical	PureTek Corporation	59088-396
Lidocaine	Lidocaine 50 mg/g	PatchTopical	Asclemed USA, Inc.	76420-037
Lidocaine	Lidocaine 50 mg/g	PatchTopical	Actavis Pharma, Inc.	0591-2679

Tridacaine II (Lidocaine) NDC 73352-830